Syngulon, a synthetic biology startup, announced its Scientific Advisory Board (SAB) comprised of leading academic and industrial experts in microbiology with experience in both Europe and the USA. In 2016, the USPTO issued US Patent 9,333,227 to Syngulon for the use of bacteriocin/immunity in any bacteria, yeast or algae for controlled growth of microorganisms. The company anticipates that the SAB will address a variety of issues at the forefront of microbial fermentation technologies from the analysis of contaminants to the choice of bacteriocin/immunity.